Adamis Pharmaceuticals (NASDAQ:ADMP) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Get Rating) in a research report released on Wednesday morning. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Price Performance Shares of NASDAQ:ADMP opened at $0.09 on Wednesday. Adamis Pharmaceuticals has a fifty-two week low of $0.08 and a […]